Pershing Square News - September 25, 2026

🟢 Pershing Square is trading at 4.7% up today after co-leading Precision Neuroscience's $250 million financing

Pershing Square is trading 4.7% higher at $54.75 after co-leading Precision Neuroscience’s oversubscribed $250 million Series D financing. - The round values...

Pershing Square co-leads $250M for Precision Neuroscience, targeting brain injury recovery

Pershing Square co-led an oversubscribed $250 million Series D financing round for Precision Neuroscience. The Ackman Oxman Institute and other life sciences...